Jo Dent

640 total citations
9 papers, 177 citations indexed

About

Jo Dent is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Jo Dent has authored 9 papers receiving a total of 177 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 3 papers in Surgery. Recurrent topics in Jo Dent's work include Gastric Cancer Management and Outcomes (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and Breast Cancer Treatment Studies (3 papers). Jo Dent is often cited by papers focused on Gastric Cancer Management and Outcomes (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and Breast Cancer Treatment Studies (3 papers). Jo Dent collaborates with scholars based in United Kingdom, United States and Netherlands. Jo Dent's co-authors include Michel Seymour, John Chester, G. Wilson, Godwin Wilson, D. Papamichael, M L Slevin, Heike I. Grabsch, Suzanne Darby, Justin S. Waters and Sharmila Sothi and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and British Journal of Cancer.

In The Last Decade

Jo Dent

9 papers receiving 170 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jo Dent United Kingdom 5 149 76 49 32 20 9 177
Irene Pecora Italy 9 130 0.9× 99 1.3× 75 1.5× 18 0.6× 20 1.0× 24 207
Hirokazu Mizuguchi United States 7 92 0.6× 57 0.8× 25 0.5× 20 0.6× 34 1.7× 11 145
Tetsuji Terazawa Japan 9 96 0.6× 84 1.1× 39 0.8× 15 0.5× 29 1.4× 41 169
Siong S Liau United Kingdom 5 103 0.7× 75 1.0× 84 1.7× 96 3.0× 10 0.5× 5 206
Chengyou Du China 7 64 0.4× 54 0.7× 45 0.9× 28 0.9× 13 0.7× 11 107
Philippe Deguiral France 7 202 1.4× 98 1.3× 47 1.0× 19 0.6× 45 2.3× 17 246
Y.S. Park South Korea 4 113 0.8× 70 0.9× 81 1.7× 15 0.5× 30 1.5× 12 147
C. Bessaguet France 4 80 0.5× 123 1.6× 104 2.1× 12 0.4× 10 0.5× 8 180
Merete Krogh Denmark 6 195 1.3× 70 0.9× 27 0.6× 19 0.6× 43 2.1× 17 233
Chimela Ohaji United States 4 80 0.5× 41 0.5× 65 1.3× 14 0.4× 32 1.6× 8 163

Countries citing papers authored by Jo Dent

Since Specialization
Citations

This map shows the geographic impact of Jo Dent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jo Dent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jo Dent more than expected).

Fields of papers citing papers by Jo Dent

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jo Dent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jo Dent. The network helps show where Jo Dent may publish in the future.

Co-authorship network of co-authors of Jo Dent

This figure shows the co-authorship network connecting the top 25 collaborators of Jo Dent. A scholar is included among the top collaborators of Jo Dent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jo Dent. Jo Dent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Verrill, Mark, Laura Pettit, Tamas Hickish, et al.. (2024). A UK prospective multicentre decision impact, decision conflict and economic evaluation of the 21-gene assay in women with node+ve, hormone receptor+ve, HER2-ve breast cancer. British Journal of Cancer. 130(7). 1149–1156. 1 indexed citations
4.
Swinson, Daniel, Mohan Hingorani, Jo Dent, et al.. (2019). Best supportive care (BSC) with or without low-dose chemotherapy (chemo) in frail elderly patients with advanced gastroesophageal cancer (aGOAC): The uncertain randomization of the GO2 phase III trial.. Journal of Clinical Oncology. 37(15_suppl). 4051–4051. 5 indexed citations
5.
Smyth, Elizabeth, Samuel Rowley, Fay Cafferty, et al.. (2019). Safety and Efficacy of the Addition of Lapatinib to Perioperative Chemotherapy for Resectable HER2-Positive Gastroesophageal Adenocarcinoma. JAMA Oncology. 5(8). 1181–1181. 18 indexed citations
6.
Hall, Peter, Simon Lord, Michelle Collinson, et al.. (2012). Three, two, or one drug chemotherapy for frail or elderly patients with advanced gastroesophageal cancer (321GO): A feasibility study.. Journal of Clinical Oncology. 30(4_suppl). 97–97. 1 indexed citations
7.
Chester, John, et al.. (2002). A ‘modified de Gramont’ regimen of fluorouracil, alone and with oxaliplatin, for advanced colorectal cancer. British Journal of Cancer. 87(4). 393–399. 110 indexed citations
8.
Chester, John, et al.. (2000). Protracted infusional 5-fluorouracil (5-FU) with bolus mitomycin in 5-FU-resistant colorectal cancer. Annals of Oncology. 11(2). 235–237. 28 indexed citations
9.
Seymour, Michel, et al.. (1999). Epirubicin, cisplatin and oral UFTwith leucovorin (‘ECU’): A phase I–II study in patients with advanced upper gastrointestinal tract cancer. Annals of Oncology. 10(11). 1329–1333. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026